Market Access and Reimbursement Insights

Thelansis’s “Market Access and Reimbursement Insights” report provides comprehensive payer insights on the current and evolving market access and reimbursement environments for branded and emerging drugs in the indication. Our team understands the criticality of payer research and insights generation, as well as their importance during drug development, pre-market launch strategy, and post-marketing activities.

Key outcomes:

  • What is the market access and reimbursement environment for current therapies for the specific disease area in the G8 markets (US, EU5, Japan, China)?
  • What are the expected market access and reimbursement requirements for the emerging therapies?
  • What are the payers’ expectations from the key emerging therapies, new policies, and their impact on decision-making?
  • What are the key factors driving or limiting the use of branded products?
  • What are the key recommendations for the manufacturer and developer to achieve optimal market access?

Reports: